Last week in GLP1 (2025/09/08)

GLP1.Guide Staff

07 Sep 2025 — 2 min read

Here’s what happened last week in the GLP1 ecosystem:

🌎 World Health Organization (WHO) adds GLP1 to essential medicines list (for diabetes)

🏛️ FDA Creates 'Green List' of GLP-1 Drug Ingredients Approved for Entry in the U.S.

🧑‍⚖️ CVS Caremark gets sued for stopping coverage of GLP1s

📰 GLP-1 Receptor Agonists Linked to Reduced Risk for Developing Uveitis

Go deeper, learn more

Here are our latest deep dives on the recent news and research behind GLP1s:

Here’s what happened last week in the GLP1 ecosystem: 📊 Study: Wegovy pill shows 16.6% weight loss 📢 Eli Lilly says Orforglipron is even better than the Wegovy pill 📺 GLP1s in patch form? Not yet 📑 GLP1s could reduce all-cause mortality by up to 6% by 2045 ❓Bariatric surgery more effective

A new study on GLP1s eye risk

One of the biggest emerging risks of using GLP1s has been the link between GLP1s and vision loss — whether via NAION or macular degeneration. We’ve covered this before: The link between Semaglutide & vision loss (NAION)How deep is the link between GLP1s and possible vision loss? We examine

Last week in GLP1 (2025/09/15)

Here’s what happened last week in the GLP1 ecosystem: 🧑‍⚖️ Lawsuits over the negative side effects of GLP1s 🌐 The WHO is building a guideline for GLP1 use and requesting comments 🎭 Celebrity endorsements continue: Andy Cohen reveals use of GLP1s for weight management 🚨 GLP1 is now being used in SMS scams

Massive GLP1 use in Silicon Valley survey

We mostly hear of increased adoption of GLP1s in the mainstream — entertainers and public figures being quizzed on whether they use it or not, spectacular transformations for patients who have found a GLP1 that works for them, etc. Silicon Valley and those that like to experiment or “bio-hack” were very

Last week in GLP1 (2025/09/08)

GLP1.Guide Staff

🌎 World Health Organization (WHO) adds GLP1 to essential medicines list (for diabetes)

🏛️ FDA Creates 'Green List' of GLP-1 Drug Ingredients Approved for Entry in the U.S.

🧑‍⚖️ CVS Caremark gets sued for stopping coverage of GLP1s

📰 GLP-1 Receptor Agonists Linked to Reduced Risk for Developing Uveitis

Go deeper, learn more

Read more

Last week in GLP1 (2025/09/22)

A new study on GLP1s eye risk

Last week in GLP1 (2025/09/15)

Massive GLP1 use in Silicon Valley survey

🌎 World Health Organization (WHO) adds GLP1 to essential medicines list (for diabetes)

🏛️ FDA Creates 'Green List' of GLP-1 Drug Ingredients Approved for Entry in the U.S.

🧑‍⚖️ CVS Caremark gets sued for stopping coverage of GLP1s📰 GLP-1 Receptor Agonists Linked to Reduced Risk for Developing Uveitis

Go deeper, learn more

Read more

Last week in GLP1 (2025/09/22)

A new study on GLP1s eye risk

Last week in GLP1 (2025/09/15)

Massive GLP1 use in Silicon Valley survey

🧑‍⚖️ CVS Caremark gets sued for stopping coverage of GLP1s

📰 GLP-1 Receptor Agonists Linked to Reduced Risk for Developing Uveitis